Alexion Pharmaceuticals (ALXN) reported third quarter EPS of $0.37 Thursday morning, which came in above the consensus estimate of $0.21. The company also increased its full year EPS forecast to between $1.15 and $1.18, from prior guidance of $1.01 to $1.06.
Alexion Pharmaceuticals gapped up sharply Thursday and climbed in early trade. Shares rose further late in the afternoon and closed higher by $3.68 at $47.81 on the highest volume in nearly 4 months. The stock broke out of a 2-month range and set a new high for the year.
For comments and feedback: editorial@rttnews.com